ZA948479B - Linear adhesion inhibitors - Google Patents

Linear adhesion inhibitors

Info

Publication number
ZA948479B
ZA948479B ZA948479A ZA948479A ZA948479B ZA 948479 B ZA948479 B ZA 948479B ZA 948479 A ZA948479 A ZA 948479A ZA 948479 A ZA948479 A ZA 948479A ZA 948479 B ZA948479 B ZA 948479B
Authority
ZA
South Africa
Prior art keywords
disorders
adhesion inhibitors
linear adhesion
linear
aiibss3
Prior art date
Application number
ZA948479A
Other languages
English (en)
Inventor
Alfred Jonczyk
Brunhilde Felding-Habermann
Beate Diefenbach
Friedrich Rippmann
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ZA948479B publication Critical patent/ZA948479B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Medicinal Preparation (AREA)
ZA948479A 1993-10-28 1994-10-27 Linear adhesion inhibitors ZA948479B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4336758A DE4336758A1 (de) 1993-10-28 1993-10-28 Lineare Adhäsionsinhibitoren

Publications (1)

Publication Number Publication Date
ZA948479B true ZA948479B (en) 1995-06-20

Family

ID=6501202

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA948479A ZA948479B (en) 1993-10-28 1994-10-27 Linear adhesion inhibitors

Country Status (16)

Country Link
US (1) US5747457A (ko)
EP (1) EP0655462B1 (ko)
JP (1) JPH07149794A (ko)
KR (1) KR950011466A (ko)
CN (1) CN1107159A (ko)
AT (1) ATE165837T1 (ko)
AU (1) AU690923B2 (ko)
CA (1) CA2134418A1 (ko)
CZ (1) CZ265594A3 (ko)
DE (2) DE4336758A1 (ko)
HU (1) HUT69179A (ko)
NO (1) NO944093L (ko)
PL (1) PL305632A1 (ko)
RU (1) RU94039288A (ko)
SK (1) SK130094A3 (ko)
ZA (1) ZA948479B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100423A (en) * 1995-08-30 2000-08-08 G. D. Searle & Co. Amino benzenepropanoic acid compounds and derivatives thereof
CN1085980C (zh) * 1995-08-30 2002-06-05 G·D·瑟尔公司 间－胍基、脲基、硫脲基或氮杂环氨基苯甲酸衍生物用作整合素拮抗剂
DE19534016A1 (de) * 1995-09-14 1997-03-20 Merck Patent Gmbh Biotinderivate
WO2000038730A2 (en) 1998-12-23 2000-07-06 G.D. Searle & Co. Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
MXPA06006319A (es) * 2003-12-03 2006-08-23 Scripps Research Inst Peptidos y anticuerpos especificos para integrina aiib??3.
CN108203465B (zh) * 2016-12-20 2022-09-02 山西医科大学 一种双重靶向抑制肿瘤细胞和肿瘤血管且性质稳定的多肽

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799670A (en) * 1954-04-13 1957-07-16 Laufer Louis Method of preparing cysteinylglycine
US4177277A (en) * 1977-01-17 1979-12-04 E. R. Squibb & Sons, Inc. Method for alleviating hypertension
JP2945680B2 (ja) * 1988-09-09 1999-09-06 旭硝子株式会社 ペプチド誘導体およびその用途
CA2009613A1 (en) * 1989-02-09 1990-08-09 Victor M. Garsky Polypeptide synthesis
AU5939890A (en) * 1989-06-07 1991-01-07 Genentech Inc. Platelet aggregation inhibitors and related molecules

Also Published As

Publication number Publication date
EP0655462A1 (de) 1995-05-31
ATE165837T1 (de) 1998-05-15
KR950011466A (ko) 1995-05-15
US5747457A (en) 1998-05-05
DE59405893D1 (de) 1998-06-10
NO944093D0 (no) 1994-10-27
SK130094A3 (en) 1995-05-10
AU690923B2 (en) 1998-05-07
NO944093L (no) 1995-05-02
HU9403100D0 (en) 1994-12-28
AU7750194A (en) 1995-05-18
RU94039288A (ru) 1996-09-10
JPH07149794A (ja) 1995-06-13
CN1107159A (zh) 1995-08-23
CA2134418A1 (en) 1995-04-29
HUT69179A (en) 1995-08-28
CZ265594A3 (en) 1995-07-12
EP0655462B1 (de) 1998-05-06
PL305632A1 (en) 1995-05-02
DE4336758A1 (de) 1995-05-04

Similar Documents

Publication Publication Date Title
TW372232B (en) Phenylalanine derivatives
EP0458641A3 (en) Use of prostaglandin derivatives in the treatment of congestive heart failure
CA2130805A1 (en) Use of mannose phosphates for the treatment of fibrotic disorders
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
FR2685642B1 (fr) Stimulateur cardiaque a frequence asservie a l'effort du patient.
AU2236388A (en) Methods for preventing and treating thrombosis; and surgical implant having reduced platelet deposition characteristics.
DK465488A (da) Farmaceutisk praeparat indeholdende en triazol-forbindelse
ZA948479B (en) Linear adhesion inhibitors
DE3474502D1 (en) Clearing treatment for blood compartments of dialysis machines
OA09917A (en) Compounds for use in treating HIV infection
EP0302595A3 (en) Pinacidil for treatment of pulmonary hypertension or right heart failure
GR3006349T3 (ko)
DE58906814D1 (de) Verwendung von ACE-Inhibitoren gegen Neointimabildung nach Gefässverletzung.
DE69121104D1 (de) Frequenzadaptierender herzschrittmacher
SE8301004L (sv) Pyridinforeningar
CA2185394A1 (en) Biotinderivate
AU2135988A (en) Benzopyridazinone and pyridopyridazinone compounds and their use in the treatment of congestive heart failure
HU910437D0 (en) Process for the production of medical preparations for treating apnoea during sleep
GR852408B (ko)
USD328346S (en) Connector for therapeutic system for treating venous ulcers
GB8817862D0 (en) Use of hydroperoxide in treatment of acne & seborrhoea
ZA844114B (en) 6(or 5)-hydroxybenzothiazole-2-sulfonamide-o-sulfate salts for the topical treatment of elevated intraocular pressure
HU913310D0 (en) Process for the production of medical preparations for treating psoreasis
HU9201316D0 (en) Process for the production of hiv treating medical preparation containing 9-amino-1,2,3,4 tetrahydro-acridine-1-ol derivatives as active agents
RU93015924A (ru) Способ лечения трофических язв нижних конечностей